drug protocol number

CLEE011ASA

drug sponsor

Novartis Saudi Ltd

drug study

kisqaLi (ribociclib)

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh) , King Faisal Specialist Hospital and Research Center (Riyadh) , King Fahad Medical City (Riyadh) , King Fahad Specialist Hospital (Dammam)

drug status

Ongoing

drug phase